Role of extended release quetiapine in the management of bipolar disorders

References

• GrantBFStinsonFSHasinDSPrevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related ConditionsJ Clin Psychiatry2005661205121516259532
   PubMed Web of Science ®Google Scholar
• DinanTGLithium in bipolar mood disorder [editorial]BMJ200232498999011976227
   PubMed Web of Science ®Google Scholar
• FountoulakisKNVietaESiamouliMTreatment of bipolar disorder: a complex treatment for a multi-faceted disorderAnn Gen Psychiatry200762717925035
   PubMedGoogle Scholar
• SajatovicMMadhusoodananSFullerMARisperidone for bipolar disordersExpert Rev Neurother2005517718715853488
   PubMedGoogle Scholar
• PopeHGMcElroySLKeckPEHudsonJIValproate in the treatment of acute mania: a placebo-controlled studyArch Gen Psychiatry19914862681984763
   PubMed Web of Science ®Google Scholar
• BowdenCLBruggerAMSwannACEfficacy of divalproex vs lithium and placebo in the treatment of maniaJAMA19942719189248120960
   PubMed Web of Science ®Google Scholar
• GoldsmithDRWagstaffAJIbbotsonTPerryCMLamotrigine: a review of its use in bipolar disorderDrugs2003632029205012962521
   PubMed Web of Science ®Google Scholar
• McElroySLKeckPEPharmacologic agents for the treatment of acute bipolar maniaBiol Psychiatry20004853955711018226
   PubMed Web of Science ®Google Scholar
• SajatovicMValensteinMBlowFCGanoczyDIgnacioRVTreatment adherence with antipsychotic medications in bipolar disorderBipolar Disord20068323224116696824
   PubMed Web of Science ®Google Scholar
• DeppCOjedaVDMastinWTrends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001–2004Psychiatr Serv2008591169117418832503
   PubMed Web of Science ®Google Scholar
• USFDAPrescribing information. Seroquel XR (quetiapine fumarate) extended-release tablets [online] Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022047s006s007s008lbl.pdf. Accessed September 10, 2009.
   Google Scholar
• US FDAPrescribing information. Seroquel (quetiapine fumarate) tablets [online]Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020639s025s037s038s040lbl.pdf Accessed September 10, 2009.
   Google Scholar
• JensenNHRodriguezRMCaronMGWetselWCRothmanRBRothBLN-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine’s antidepressant activityNeuropsychopharmacology2008332303231218059438
   PubMed Web of Science ®Google Scholar
• AltschulerELKastREUsing histamine (H1) antagonists, in particular atypical antipsychotics to treat anemia of chronic disease via interleukin-6 suppressionMed Hypoth2005656567
   PubMed Web of Science ®Google Scholar
• LicinioJWongMLThe role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotectionMol Psychiatry1999431732710483047
   PubMed Web of Science ®Google Scholar
• Medicine evaluation boardPublic assessment report of the medicines evaluation board in the Netherland [online] Available from: http://db.cbg-meb.nl/mri/par/nlh-0156-008-009-010-011.pdf. Accessed September 10, 2009.
   Google Scholar
• Electronic Medicines CompendiumSeroquel Xl 50 mg, 200 mg, 300 mg, 400 mg prolonged release tablets [online]Available from: http://emc.medicines.org.uk/medicine/21175/SPC/Seroquel%20XL%2050%20mg,%20200%20mg,%20300%20mg,%20400%20mg%20prolonged-release%20tablets/ Accessed September 10, 2009.
   Google Scholar
• FigueroaCBrecherMHamer-MaanssonJEWinterHPharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate releaseProg Neuropsychopharmacol Biol Psychiatry20093319920418948162
   PubMed Web of Science ®Google Scholar
• CutlerADattoCNordenhemAEffectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar mania [poster]Presented at the 8th Annual International Review of Bipolar Disorders ConferenceApril 14–162008Copenhagen Denmark
   Google Scholar
• SuppesTDattoCMinkwitzMNordenhemAWalkerCDarkoDEffectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression [poster]Presented at the 8th Annual International Review of Bipolar Disorders ConferenceApril 14–162008Copenhagen Denmark
   Google Scholar
• BowdenCLGrunzeHMullenJA randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorderJ Clin Psychiatry20056611112115669897
   PubMed Web of Science ®Google Scholar
• MöllerHJJohnsonSMatevaTEvaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophreniaInt Clin Psychopharmacol2008239510518301124
   PubMed Web of Science ®Google Scholar
• CalabreseJRKeckPEMacfaddenWA randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depressionAm J Psychiatry20051621351136015994719
   PubMed Web of Science ®Google Scholar
• ThaseMEMacfaddenWWeislerRHEfficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (The BOLDER II Study)J Clin Psychopharm200626600609
   PubMed Web of Science ®Google Scholar
• TohenMBakerRWAltshulerLLOlanzapine versus divalproex in the treatment of acute maniaAm J Psychiatry20021591011101712042191
   PubMed Web of Science ®Google Scholar
• YathamLPaulssonBMullenJVageröAMQuetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar ManiaJ Clin Psychopharm200424599606
   PubMed Web of Science ®Google Scholar
• Al JurdiRKMarangellLBPetersenNJMartinezMGyulaiLSajatovicMPrescription patterns of psychotropic medications in elderly compared with younger participants who achieved a “recovered” status in the systematic treatment enhancement program for bipolar disorderAm J Geriatr Psychiatry20081692293318978253
   PubMed Web of Science ®Google Scholar
• ClaxtonAJCramerJPierceCA systematic review of the association between dose regimens and medication complianceClin Therap2001231296131011558866
   PubMed Web of Science ®Google Scholar
• YathamLNKennedySHSchafferACanadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009Bipolar Disord20091122525519419382
   PubMed Web of Science ®Google Scholar
• SajatovicMValensteinMBlowFGanozcyDIgnacioRTreatment adherence with lithium and anticonvulsant medications among patients with bipolar disorderPsychiatric Services20075885586317535948
   PubMed Web of Science ®Google Scholar
• PerlickDARosenheckRAKacynskiRMedication non-adherence in bipolar disorder: a patient-centered review of research findingsClinical Approaches in Bipolar Disorders200435456
   Google Scholar
• LinghamRScottJTreatment non-adherence in affective disordersActa Psychiatr Scand2002150164172
   Web of Science ®Google Scholar